Media CentreCareersInvestors EN Contact Us
About Us
Back
About Us
Kamaptive Technology
Kamaptive Partnerships
Kamaptive Devices
Healthcare Professionals
Back
Healthcare Professionals
Pioneer Clinical Educational Programme
Improving Patient Pathways with SSD
Clinical Resources & Information
Case Gallery
Medical Specialities
Educational Webinars
Patients
Back
Patients
Patient Case Stories
Products
Back
Products
Advanced Energy
Gastroenterology
Pulmonology
Urology
Resection
Ablation
Diagnostics
Therapeutics
Hygiene
Diagnostics
Therapeutics
Diagnostics
Therapeutics
Media CentreCareersInvestors EN Contact Us

Media Centre

Latest News, Events and more from Creo Medical

Featured News
24 April 2024
NHS Supply Chain real-world data demonstrates substantial cash savings
Case study by an NHS Trust sets out the cash savings and operational benefits gained from the use of Creo’s Speedboat technology…
Read more

News

24 April 2024

NHS Supply Chain real-world data demonstrates substantial cash savings

Read
19 March 2024

Welsh Labour Leader visits Creo’s facilities

Read
05 February 2024

Strategic Collaboration with Khalifa University of Science and Technology, Abu Dhabi

Read
31 January 2024

Roll-out of Speedboat® UltraSlim reaches Asia Pacific

Read
10 January 2024

First Use of Speedboat® UltraSlim in Latin America

Read
13 December 2023

First European Speedboat® UltraSlim procedure marks early commercial launch

Read
01 November 2023

Speedboat® UltraSlim: US FDA Clearance

Read
25 October 2023

Speedboat UltraSlim: EU launch accelerated by 18 months

Read
12 September 2023

Half Year Report: H1-2023

Read
19 June 2023

Speedboat Inject cleared for upper GI use in Europe

Read
01 June 2023

Speedboat™ Inject selected by NICE for assessment

Read
23 May 2023

First in-human milestone reached for MicroBlate™ Flex as part of Lung Tissue ablation clinical study

Read
17 May 2023

Royal Oldham becomes first NHS hospital to immediately implement CROMA and Speedboat™ Inject across multiple endoscopy rooms

Read
15 May 2023

2023 Digestive Disease Week the most significant in Creo history

Read
05 April 2023

Welsh Government grant to support further growth

Read
31 March 2023

MicroBlate™ Flex clinical study in lung lesion microwave ablation

Read
31 January 2023

Gwent firm turns heads and transforms lives globally

Read
11 January 2023

FY 2022 Trading Update

Read
28 October 2022

Creo Medical ‘putting Wales on the map’

Read
24 October 2022

Kamaptive Licence and Royalty Agreement with CMR Surgical

Read
22 September 2022

Chris Hancock elected as a Fellow of Royal Academy of Engineering

Read
03 August 2022

H1 2022 Trading Update

Read
28 June 2022

AGM Statement

Read
27 June 2022

Clinical Education update and Digestive Disease Week conference round-up

Read
23 May 2022

Building momentum: Strong strategic and operational progress

Read
23 May 2022

Collaboration agreement with Intuitive

Read
16 May 2022

‘I owe my life to hospital teams – and my wife!’

Read
28 April 2022

Creo Medical Group sales momentum continuing into 2022

Read
20 April 2022

Creo opens Singapore regional hub

Read
05 April 2022

Creo CTO & Founder wins inaugural Technology Innovator of the Year Award at European Microwave Week

Read
31 March 2022

Strong start to 2022 continues as Creo completes multi-national training course

Read
30 March 2022

Creo Medical awarded with Gold RoSPA Award

Read
21 February 2022

Creo Medical team up with Chepstow School to plant 200 trees

Read
17 February 2022

Mewburn Ellis article – Spotlight on Creo Medical

Read
03 February 2022

Trading update

Read
24 January 2022

Kamaptive Technology Licensing & Partnership update

Read
03 December 2021

Creo Medical wins Innovation award

Read
12 November 2021

Acquisition of Aber Electronics Limited

Read
30 September 2021

Half-year Report

Read
16 July 2021

Opening of United States, East Coast Headquarters

Read
16 June 2021

MicroBlate Fine’s first in-human use update

Read
14 June 2021

Acquisition of freehold site for £4.25m

Read
26 May 2021

Further health economics data validates Creo technology

Read
17 February 2021

Strong regulatory and commercial progress achieved despite worldwide COVID-19 restrictions

Read
07 January 2021

US FDA clearance for MicroBlate™ Flex device

Read
03 November 2020

Acquisition of Boucart Medical SRL

Read
02 November 2020

US FDA clearance for MicroBlate™ Fine device

Read
23 September 2020

Half-year Report

Read
24 July 2020

Acquisition of Albyn Medical S.L.

Read
10 July 2020

Secretary of State for Wales visit

Read
02 July 2020

Development loan for plasma sterilising product

Read
15 June 2020

CE mark for five new devices

Read
03 June 2020

Positive NHS health economics data

Read
20 November 2019

First in-human cases in India

Read
22 October 2019

Commercial Launch of Speedboat at UEG Week in Barcelona

Read
05 July 2019

Institute of Physics Award & Royal Academy of Engineering Visiting Professor appointment

Read
25 June 2019

First commercial orders for Speedboat

Read
13 May 2019

Annual Report and Accounts

Read
05 April 2019

Full results for the 18 months ended 31 December 2018

Read
28 March 2019

Update on US Clinical Education Programme

Read
18 March 2019

Creo founder named in Sunday Times list of top 100 UK entrepreneurs

Read
16 January 2019

First use of Speedboat in the US

Read
03 December 2018

First placement and use of Speedboat in Europe

Read
19 October 2018

UK Endoscopy Training Course

Read
17 October 2018

Spain & Benelux Framework Distribution Agreements

Read
28 September 2018

Interim results for six months ended 30 June 2018

Read
13 September 2018

First placement and use of Speedboat in South Africa

Read
13 July 2018

Conditional Placing of new Shares significantly oversubscribed

Read
09 July 2018

South African Framework Distribution Agreement with First Medical Company

Read
04 July 2018

UK Framework Distribution Agreement with Diagmed Healthcare

Read
02 June 2018

Market Update

Read
20 March 2018

Interim results for six months to 31 December 2017

Read
29 November 2017

Speedboat RS2 utilised at second NHS site

Read
14 November 2017

Preliminary Financial Results for the financial year ending 30 June 2017

Read
21 August 2017

Creo announces US FDA Approval of Speedboat RS2

Read
17 June 2017

Creo Medical Announces First Patient Treated with Speedboat

Read
All news

From the Video Gallery

Patients on their treatment experience with Speedboat Inject

Patients Mary and Chris recount their experiences of being treated under the Complex Polyp Service at East Kent Hospital University Foundation Trust using Speedboat Inject and its advanced energy technology

Watch now

ScopeGrasp - Grasping Forceps in action

See how ScopeGrasp grasping forceps can be used to grasp tissue, stones, stents or foreign bodies

Watch now

Introducing Creo Medical

Learn more about Creo Medical, who we are and what we do in this short introduction video

Watch now

Speedboat Inject: POEM Procedural Animation

See how Speedboat Inject can be used to perform a Per-oral Endoscopic Myotomy (POEM) procedure in this animation

Watch now
All videos

Events and Webinars from Creo Medical

Event

26 June 2024 09:00 AM

Upper GI Endoscopy and Nottingham Barrett’s Endotherapy Course

Book now

Event

17 June 2024 09:00 AM

British Society Gastroenterology (BSG) Exhibition and EndoVillage

Book now

Event

06 June 2024 09:00 AM

Cleveland Clinic: Endoscopic Intramural Surgery/Third Space Endoscopy

Book now

Event

18 May 2024 06:00 AM

Digestive Disease Week 2024

Book now

Event

12 May 2024 09:00 AM

Endoport 2024: Portsmouth Advanced Endoscopy Symposium

Book now

Event

02 May 2024 09:00 AM

TxIEG 4th Annual Transluminal & Third Space Endoscopy Course

Book now

Event

25 April 2024 09:00 AM

ESGE Days 2024

Book now

Webinar

05 October 2023 05:30 PM

Managing UGI Diseases with an Innovative Advanced Energy Platform

Register

Webinar

23 February 2023 05:30 PM

EMR to SSD: The benefits of expanding your treatment options for polyps & lesions

Register

Webinar

13 December 2022 05:30 PM

Establishing a Third Space Endoscopy Program

Register

Webinar

05 September 2021 05:30 PM

Speedboat Submucosal Dissection (SSD) — The Learning Journey from Advanced EMR to SSD

Register

Webinar

05 September 2021 05:30 PM

Innovations in Therapeutic Endoscopy

Register

Webinar

07 May 2021 05:30 PM

Piecemeal or en-bloc dissection? A new technology trend for submucosal dissections

Register

Webinar

23 June 2020 05:30 PM

Bringing Advanced Energy to Endoscopic Submucosal Dissection (ESD)

Register
All eventsAll webinars

Case studies

Case study

Speedboat Submucosal Dissection (SSD) using Advanced Energy for a LST-mixed lesion in the rectum extending to the dentate line

Read

Case study

Per-oral Endoscopic Myotomy Using a Novel Bipolar Speedboat Device

Read

Case study

Speedboat Submucosal Dissection (SSD) Using Advanced Energy on a Mid-Rectal Lateral Spreading Tumour with Focal Depression of Lower Rectum

Read
All case studies

Downloads

Leakage Master IFU - EN

05 December 2023

Download

Scope Cleaner IFU - EN

Download

ScopeBite IFU - EN/FR/ES/DE/NL

Download

Swinging ScopeBite IFU - EN/FR/ES/DE/NL

Download

ScopeSnare IFU - EN/FR/ES/DE/NL

Download
All downloads

Get all Latest News and Events direct to your inbox

Healthcare Professionals
Online CommunityPioneers Cases GalleryImproving Patient PathwaysCase StudiesHealthcare Professionals
About Us
About UsKamaptive Advanced EnergyKamaptive PartnershipsMedia CentreCareersSustainability Policy
Products
All ProductsKamaptive DevicesGastroenterologyUrologyPulmonology
Other
InvestorsCookie PolicyTerms of UsePrivacy PolicyContact
© 2024 Creo Medical. All rights reserved
This information contained in this website is intended as general information to demonstrate Creo Medical’s product range for healthcare professionals only and not the general public. Not all products are cleared/approved for use in all territories, and accordingly the availability of products may vary depending on the territory and current regulatory requirements and/or medical practices in such territory. Please read our full disclaimer for further details.